Johnson & Johnson announced a stock repurchase of up to $5 billion on Monday, following Friday’s Reuters report that the healthcare conglomerate knew for decades that its Baby Powder contained cancer-causing asbestos, which wiped off about $40 billion from the company’s market capitalisation.
